GENEVA, Sept. 15 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No. 7 Kunlunshan Road, Economic And Technological Development Zone,Lianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2025/080682) for "USE OF ANTI-ANGPTL3 ANTIBODY IN TREATING HYPERLIPIDEMIA AND METHOD" on Mar 05, 2025. With publication no. WO/2025/185644, the details related to the patent application was published on Sep 11, 2025.
Notably, the patent application was submitted under the International...